No. They are waiting for each of them to be assessed by their doctors to assess their adrenal mass etc and compare to what our diagnostic predicted to compare results. This is a robust process however if this is going to take 2 years I doubt.
Also while the Ann said minimum 500 patients, the clinical trials link says 1000 patients. So that’s their target.
The main question given the prevalence of ovarian cancer and hence the number of tests that their doctors should be recommending their patients would this really take 2 years? I am hoping sooner esp if they plan to open more trial sites including in Australia which will be managed directly by the company instead of the CRO.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)